Paul Tudor Jones Astrazeneca PLC Transaction History
Tudor Investment Corp Et Al
- $25.1 Billion
- Q4 2024
A detailed history of Paul Tudor Jones (Tudor Investment Corp Et Al) transactions in Astrazeneca PLC stock. As of the latest transaction made, Tudor Investment Corp Et Al holds 32,100 shares of AZN stock, worth $2.45 Million. This represents 0.01% of its overall portfolio holdings.
Number of Shares
32,100
Previous 5,300
505.66%
Holding current value
$2.45 Million
Previous $412,000
410.44%
% of portfolio
0.01%
Previous 0.0%
Shares
4 transactions
Others Institutions Holding AZN
# of Institutions
1,365Shares Held
512MCall Options Held
6.08MPut Options Held
4.44M-
Price T Rowe Associates Inc Baltimore, MD60.4MShares$4.6 Billion0.46% of portfolio
-
Primecap Management CO Pasadena, CA41MShares$3.13 Billion2.12% of portfolio
-
Capital International Investors Los Angeles, CA37.5MShares$2.86 Billion0.48% of portfolio
-
Wellington Management Group LLP Boston, MA37MShares$2.82 Billion0.46% of portfolio
-
Bank Of America Corp Charlotte, NC24MShares$1.83 Billion0.13% of portfolio
About ASTRAZENECA PLC
- Ticker AZN
- Exchange OTC
- Sector Healthcare
- Industry Drug Manufacturers—General
- Shares Outstandng 3,099,020,032
- Market Cap $236B
- Description
- AstraZeneca PLC, a biopharmaceutical company, focuses on the discovery, development, manufacturing, and commercialization of prescription medicines. Its marketed products include Calquence, Enhertu, Faslodex, Imfinzi, Iressa, Koselugo, Lumoxiti, Lynparza, Orpathys, Tagrisso, and Zoladex for oncology; Brilinta/Brilique, Bydureon/Byetta, BCise, By...